PVLA Kronos AI forecast
A 30-trading-day price forecast for Palvella Therapeutics Inc. (PVLA) from Kronos AI, an open-source foundation model trained on candlestick charts.
Kronos AI's median forecast puts Palvella Therapeutics Inc. at $120.61 on 2026-12-08, −9.3% from the last close of $132.91 on 2026-10-27. Eight out of ten sampled paths end between $117.50 and $144.76, and 2 of the 8 paths finish above today's price.
Forecast path
median, with the 10–90% band of the sampled pathsOpen the interactive forecast → Full analysis of PVLA
The forecast, week by week
| Date | Median | Low (10%) | High (90%) |
|---|---|---|---|
| 2026-11-03 | $140.44 | $133.11 | $148.37 |
| 2026-11-10 | $136.45 | $125.34 | $161.44 |
| 2026-11-17 | $132.37 | $122.23 | $154.21 |
| 2026-11-24 | $126.92 | $114.57 | $153.31 |
| 2026-12-01 | $126.56 | $114.41 | $145.10 |
| 2026-12-08 | $120.61 | $117.50 | $144.76 |
What is Kronos AI?
Kronos is an open-source foundation model for financial candlesticks, pre-trained on K-line data from more than 45 exchanges. Gnzub runs it on each stock's last 120 daily bars and samples several possible futures, so the forecast is a range of outcomes rather than one confident line. It is a statistical model, not an analyst: it reads price patterns only and knows nothing about news, earnings or the business.
Questions
- What is the Kronos AI forecast for PVLA?
- Kronos AI's median forecast for PVLA is $120.61 in 30 trading days, −9.3% from the last close, with a 10–90% range of $117.50 to $144.76.
- Is the PVLA Kronos forecast a buy or sell signal?
- No. It is the output of a statistical model that reads price history only. It is not investment advice, and the range shows how uncertain the model is.
- How often is the forecast updated?
- The forecasts are regenerated regularly; this one starts from the close of 2026-10-27.
Kronos forecasts for similar companies
- LLY — Eli Lilly and Company
- JNJ — Johnson & Johnson
- ABBV — AbbVie Inc.
- MRK — Merck & Company Inc.
- NVS — Novartis AG
- AZN — AstraZeneca PLC